dehydroepiandrosterone sulfate has been researched along with Urinary Tract Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneda, T; Miwa, Y; Yokoyama, O | 1 |
| Chrisp, C; Miller, RA | 1 |
2 other study(ies) available for dehydroepiandrosterone sulfate and Urinary Tract Diseases
| Article | Year |
|---|---|
Association between lower urinary tract symptoms and serum levels of sex hormones in men.
Topics: Age Factors; Aged; Dehydroepiandrosterone Sulfate; Erectile Dysfunction; Estradiol; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Luteinizing Hormone; Male; Middle Aged; Prolactin; Prostate-Specific Antigen; Testosterone; Urologic Diseases | 2008 |
Lifelong treatment with oral DHEA sulfate does not preserve immune function, prevent disease, or improve survival in genetically heterogeneous mice.
Topics: Adenocarcinoma; Administration, Oral; Age Factors; Analysis of Variance; Animals; Antibody Formation; Cause of Death; Confidence Intervals; Dehydroepiandrosterone Sulfate; Double-Blind Method; Female; Immunity, Cellular; Immunization; Longevity; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred Strains; Placebos; Rodent Diseases; Survival Rate; T-Lymphocyte Subsets; Urologic Diseases | 1999 |